Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 19 , ISSUE 12 ( 2015 ) > List of Articles

LETTER TO EDITOR

The highest (3600 IU) reported overdose of insulin glargine ever and management

Fatih Karatas, Suleyman Sahin, H. Gulsah Karatas, Pinar B. Karsli, Cengizhan Emre, Fatih Kivrakoglu

Citation Information : Karatas F, Sahin S, Karatas HG, Karsli PB, Emre C, Kivrakoglu F. The highest (3600 IU) reported overdose of insulin glargine ever and management. Indian J Crit Care Med 2015; 19 (12):750-751.

DOI: 10.4103/0972-5229.171418

License: CC BY-ND 3.0

Published Online: 01-12-2015

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract
PDF Share
  1. Owens DR, Griffiths S. Insulin glargine (Lantus). Int J Clin Pract 2002;56:460-6.
  2. Reinhart L, Panning CA. Insulin glargine: A new long-acting insulin product. Am J Health Syst Pharm 2002;59:643-9.
  3. Lu M, Inboriboon PC. Lantus insulin overdose: A case report. J Emerg Med 2011;41:374-7.
  4. Dunn CJ, Plosker GL, Keating GM, McKeage K, Scott LJ. Insulin glargine: An updated review of its use in the management of diabetes mellitus. Drugs 2003;63:1743-78.
  5. Chan WB, Ngai WW, Tong PC. Treatment satisfaction with ınsulin glargine in ınsulin-naive type 2 diabetes patients - A Hong Kong based registry. J Diabetes Mellitus 2014;4:232-41.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.

We use cookies on this site to enhance your user experience.

By clicking any link on this page you are giving your consent for us to set cookies.